Lorena Taricani

Statistics

Publications

Citations

586

H-Index

Active since

1995

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Queen's University

Novartis (United States)

Northwestern University

George Washington University

Lorena Taricani is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in molecular biology, life sciences, and dna damage signaling.

Publications per year

1995–2014

Publications

Targeting the Replication Checkpoint Using SCH 900776, a Potent and Functionally Selective CHK1 Inhibitor Identified via High Content Screening

Timothy J. Guzi, Kamil Paruch, Michael P. Dwyer et al. · Molecular Cancer Therapeutics · 2011 · 171 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

A Synthetic Lethal Screen Reveals Enhanced Sensitivity to ATR Inhibitor Treatment in Mantle Cell Lymphoma with ATM Loss-of-Function

Daniel L. Menezes, Jenny Holt, Yan Tang et al. · Molecular Cancer Research · 2014 · 102 citations

Life Sciences, Cancer Biology, Oncology +17

Expression of hsp16 in response to nucleotide depletion is regulated via the spc1 MAPK pathway in Schizosaccharomyces pombe

Lorena Taricani · Nucleic Acids Research · 2001 · 42 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16

Structure-Based Drug Design of Novel Potent and Selective Tetrahydropyrazolo[1,5-<i>a</i>]pyrazines as ATR Inhibitors

Paul A. Barsanti, Robert J. Aversa, Xianming Jin et al. · ACS Medicinal Chemistry Letters · 2014 · 41 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Replication stress activates DNA polymerase alpha-associated Chk1

Lorena Taricani, David Parry · Cell Cycle · 2009 · 40 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

1–5 of 14